Soolantra Cream

The active ingredient in Soolantra is called Ivermectin. This works as an anti-inflammatory which reduces the redness associated with rosacea. In addition, ivermectin also kills parasites which cause inflamed skin in rosacea sufferers known as demodex mites.

If you miss a dose, then treatment should be applied as soon as you remember. If this is close to when the next dose would be due, do not apply a double dose. Instead continue as normal from when the next dose would be due.

There are no reports of overdosage with Soolantra. Accidental exposure to unknown quantities of veterinary products containing ivermectin in humans has resulted in rash, oedema, headache, dizziness, gastrointestinal effects (nausea, vomiting and diarrhoea). Other reported effects have included seizure, ataxia, dyspnea, abdominal pain, paresthesia, urticaria and contact dermatitis.

Where accidental ingestion is suspected, supported therapy should be initiated such as fluids and electrolytes. Respiratory support may be required a pressor agents needed if significant hypotension is present.

Should you suspect you have used too much Soolantra, or you have accidentally ingested some of the product, medical advice should be sought immediately.Should you suspect you have used too much Soolantra, or you have accidentally ingested some of the product, medical advice should be sought immediately.

Soolantra is a prescription only medicine. This means that the medication can only be issued following the presentation of a valid NHS or Private prescription. At PrivateDoc we have a team of GMC and GPhC registered doctors and pharmacists, all with many years of experience in prescribing for skincare issues. Once a consultation is completed, this is reviewed by one of our prescribers. If deemed appropriate, a prescription is issued and sent securely to our GPhC registered pharmacy, where the treatment will be dispensed and shipped securely.

Soolantra cream is used to treat the inflammatory lesions caused by rosacea in adult patients.

There is little to no data available of the safety profile of Soolantra in pregnant females. Oral studies in animals have shown teratogenic effects. Although the systemic absorption from topical preparations in humans is not likely to cause harm, the cream is not indicated for pregnant females.

Following oral administration, ivermectin is excreted into breast milk. Concentrations in human milk following topical administration have not been established. A theoretical risk to a breastfed child cannot be excluded. The decision to treat should be based on whether the risks of not treating outweigh the benefits of breastfeeding the child (in which case breastfeeding should stop and treatment started).

Each gram of Soolantra cream contains 10mg of ivermectin.

For a full list of excipients click here.